Gsk Share Discussion Threads

[montyhedge] 16/9/2020 12:32

GSK of course so liquid, traders use it like a ATM machine need money for losses elsewhere sell GSK, I do anyway, lol.

[tradermichael] 16/9/2020 08:52

US pharmaceutical firm Gilead is set to buy cancer drug-maker Immunomedics in a $21bn tie-up.

[dudishes] 14/9/2020 17:29

Gecko post 22096, WD, we must understand the perspective!

[geckotheglorious] 14/9/2020 10:53

Interesting to see Astra back in the hunt....


"AZN resumes Covid-19 trials after halt over adverse reaction"
The company said in a statement that "the standard review process had triggered a voluntary pause," to all global trials on September 6, and that the Medicines Health Regulatory Authority had given the green light to resume the trials conducted through the University of Oxford after reviewing the safety data.

The company says that it will "continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic."

While the company has been approved to continue testing in the UK, it is unclear whether they can resume trials elsewhere.

[alphorn] 14/9/2020 09:48

Abbvie & Calico also have/had a recent project on ageing btw. There always needs to be an element of blue sky research to make big steps forwards. All about risk/reward.

[montyhedge] 12/9/2020 12:27

Stock of the day. Gsk.https://www.businesslive.co.za/bd/markets/2020-09-11-watch-stock-picks-glaxosmithkline-and-apple/

[geckotheglorious] 12/9/2020 08:09

COVID-19 vaccine trials ramp up as world awaits efficacy data
Data readouts could start as early as month-end or early October.

A search in ClinicalTrials.gov identified the following Phase 3 trials:

AstraZeneca's (with University of Oxford) (NYSE:AZN) AZD1222: 100-subject open-label study in Russia. Two doses 28 days apart. Estimated start date: August 26. Estimated primary completion date: March 5, 2021. Estimated study completion date: March 5, 2021.

AZD1222: Global 30K-subject randomized parallel assignment study. Two doses 28 days apart. Estimated start date: August 17. Estimated primary completion date: December 2. Estimated study completion date: October 5, 2022.

University of Oxford's ChAdOx1. Single dose and two doses 4-6 weeks apart. 12,330-subject study in the UK. Estimated start date: May 28. Estimated primary completion date: August 2021. Estimated study completion date: August 2021.

University of Oxford's ChAdOx1. Single dose and two doses 4-12 weeks apart. 5K-subject study in Brazil. Estimated start date: June 2. Estimated primary completion date: September 2021. Estimated study completion date: September 2021.

Sinovac Life Sciences' (NASDAQ:SVA) Absorbed COVID-19 (inactivated) Vaccine. 8,870 subject study in Brazil. Two doses 14 days apart. Start date: July 21. Estimated primary completion date: September 2021. Estimated study completion date: October 2021.

Gamaleya Research Institute's Gam-COVID-Vac. 40K-subject study in Russia. Two doses 21 days apart (+/- 2 days). Estimated start date: August 31. Estimated primary completion date: May 1, 2021. Estimated study completion date: May 1, 2021.

China National Biotec Group's Vero Cell inactivated vaccine. 45K-subject study in Bahrain and UAE. Two doses 21 days apart. Estimated start date: July 16. Estimated primary completion date: March 16, 2021. Estimated study completion date: September 16, 2021.

Fundació Institut Germans Trias i Pujol's RUTI Vaccine. Two doses 14 days apart (+/- 3 days). 315-subject study in Spain. Estimated start date: July 30. Estimated primary completion date: December. Estimated study completion date: December.

CanSino Biologics' Ad5-nCoV (AAV5 vector). Single dose. 40K-subject study in China. Estimated start date: August 30. Estimated primary completion date: December 30, 2021. Estimated study completion date: January 30, 2022.

NPO Petrovax's Ad5-nCov (AAV5 vector). Single dose. 500-subject study in Russia. Estimated start date: September 7. Estimated primary completion date: November 30. Estimated study completion date: July 31, 2021.

Moderna's (NASDAQ:MRNA) mRNA-1273. Two doses 28 days apart. 30K-subject study in U.S. Estimated start date: July 27. Estimated primary completion date: October 27, 2022. Estimated study completion date: October 27, 2022.

PT Bio Farma's SARS-CoV-2 Vaccine (inactivated). Two doses 14 days apart. 1,620-subject study in Indonesia. Estimated start date: August 10. Estimated primary completion date: January 2021. Estimated study completion date: September 2021.

Pfizer (NYSE:PFE)/BioNTech's (NASDAQ:BNTX): BNT162b2. Two doses 21 days apart. Global 29,481-subject study. Estimated start date: April 29. Estimated primary completion date: April 19, 2021. Estimated study completion date: November 14, 2022.

Johnson & Johnson's (NYSE:JNJ) Ad26.COV2.S. Single dose. Global 60K-subject study. Estimated start date: September 5. Estimated primary completion date: March 10, 2023. Estimated study completion date: March 10, 2023.

Sanofi (NASDAQ:SNY) and adjuvant supplier GlaxoSmithKline (NYSE:GSK) launched a Phase 1/2 study of their vaccine candidate last week. A Phase 3 should start by year-end.

[montyhedge] 10/9/2020 16:01

Pound getting weaker, great for the U.K. Footsie dollar earners.

[geckotheglorious] 10/9/2020 11:18

FDA OKs expanded use of Glaxo's Trelegy Ellipta in asthma

The FDA has approved a new indication for GlaxoSmithKline ;(NYSE:GSK) and Innoviva's (NASDAQ:INVA) Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to its current license for use in patients with chronic obstructive pulmonary disease (COPD).

[dudishes] 10/9/2020 11:03

Green tick, just to balance!

[alphorn] 10/9/2020 09:12

#088. I would not necessarily red tick that post whoever did it.

There are various projects for true blue sky research. One fascinating project is all about regrowth. Once you have an animal model then the challenge is to understand it and replicate it for humans. Talking to one of our founders 30yrs+ ago he had a project around this subject. Think of those animal models who can regrow parts, what about a foetus itself? The first results are helping nerves.
A starting point for age could be Progeroid syndromes (PS) which are a group of rare genetic disorders which mimic physiological aging. Understand it and reverse it? No ideas at all on this one but don't red tick it.

[montyhedge] 10/9/2020 08:28

Shareprice taking a breather, perhaps use they own inhaler, lol.With all this good news should be more around 1600p than 1500p.

[montyhedge] 10/9/2020 08:03

Another great rns this morning, the good news just keeps coming.

[agereset] 10/9/2020 06:40

Please help.
Do you know of any listed company that is focused on age reversal subject?

[essentialinvestor] 10/9/2020 06:29

Some more good news:

[buywell3] 09/9/2020 21:46

===== Covid-19 --- buywell does not think it will be a yearly jab ======

Reading many public published articles , the consensus is IMO that immunity from people that recover from Covid-19 can be as little as 2M to around 4M

Antibodies drop off very fast in the majority of recovered people after just a few weeks and at circa 3M the majority have around 10% left which then continue to drop away.

It is difficult to see any vaccine giving immunity that lasts longer than 4M IMO especially any that use previous de-activated coronaviruses or antibodies from recovered cases.

Hence any vaccine IMO will need to be administered 3 times every year

Quite how effective such a vaccine would be say after having it 5 times re the protection it gave V the first dose --- remains to be seen

As does repeated taking of the same quantity or booster doses of the same chemical compound ie long-term toxicity .

In normal times for example where a vaccine would take say 10 to 12 years to approval/ production and use --- long term toxicity issues have IMO a better chance of being spotted ie Phase 3 human trials of 1 year and longer.

This is why IMO circa 40% of the world population will be Covid-19 vaccine averse .

imo dyor







boris' rule of 6 does apply to pubs and restaurants, cafes wine bars etc



appologies will be considered for acceptance

[dudishes] 09/9/2020 17:34

QP, Pres & Co.Sec share issues were bonus payments (2015 agreement), not buys.

At 14.35, a nice little earner with todays performance.

I am a holder.

[badtime] 09/9/2020 15:28

A certain poster seems to have disappeared during an up day ...chuckle

[montyhedge] 09/9/2020 10:07

Also pound below 1.30 and falling good for U.K. dollar earners.

[quepassa] 09/9/2020 09:24

the money is on gsk.

rightly so

[montyhedge] 09/9/2020 09:22

I prefer GSK, at least getting a dividend cheque on the doormat every 13 weeks, while we wait for 2150p which is coming. Safe 5.2% yield what's not to like.

[geckotheglorious] 09/9/2020 09:19

Anyone doing a "pairs trade"

Astra seems very overvalued, GSK decent value.

Sell AZN/Buy GSK.

Bought some GSK myself Monday..